Literature DB >> 9505733

The impact of psoriasis on psychosocial life domains. A review.

A Wahl1.   

Abstract

Living with a chronic disease, such as psoriasis, is likely to have psychological as well as social implications. Hence, knowledge about the impact of psoriasis on patients' life situation is important for designing and selecting suitable health care programmes for this group of patients. A review of studies published between 1983 and 1995 shows that there are some common factors as regards the psychological distress and social and functional limitations this group of patients has to deal with. However, it is difficult to compare the findings on the psychosocial impact of psoriasis owing to the differences in methods, study design and patient samples. This suggests that further research is needed. A holistic perspective that includes patients' quality of life may represent a fruitful approach.

Entities:  

Mesh:

Year:  1997        PMID: 9505733     DOI: 10.1111/j.1471-6712.1997.tb00463.x

Source DB:  PubMed          Journal:  Scand J Caring Sci        ISSN: 0283-9318


  6 in total

1.  The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis.

Authors:  A Wahl; T Moum; B R Hanestad; I Wiklund
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

2.  Coping and quality of life in patients with psoriasis.

Authors:  A Wahl; B R Hanestad; I Wiklund; T Moum
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

3.  The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.

Authors:  Richard Shikiar; Mary Kaye Willian; Martin M Okun; Christine S Thompson; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2006-09-27       Impact factor: 3.186

4.  Self-management in daily life with psoriasis: an integrative review of patient needs for structured education.

Authors:  Gitte Susanne Rasmussen; Helle Terkildsen Maindal; Kirsten Lomborg
Journal:  Nurs Res Pract       Date:  2012-12-06

5.  Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.

Authors:  Dennis A Revicki; Alan Menter; Steven Feldman; Miriam Kimel; Neesha Harnam; Mary K Willian
Journal:  Health Qual Life Outcomes       Date:  2008-10-02       Impact factor: 3.186

6.  Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.

Authors:  Richard Shikiar; Brian W Bresnahan; Stephen P Stone; Christine Thompson; John Koo; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2003-10-08       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.